| 000 | 01831 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515013330.0 | ||
| 264 | 0 | _c20060627 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0959-4973 | ||
| 024 | 7 |
_a10.1097/00001813-200602000-00008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Xia | |
| 245 | 0 | 0 |
_aDifference of cell cycle arrests induced by lidamycin in human breast cancer cells. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cFeb 2006 |
||
| 300 |
_a173-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAminoglycosides _xpharmacology |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCDC2 Protein Kinase _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 | _aCheckpoint Kinase 2 |
| 650 | 0 | 4 |
_aCyclin B _xgenetics |
| 650 | 0 | 4 | _aCyclin B1 |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism |
| 650 | 0 | 4 | _aEnediynes |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aGenes, Tumor Suppressor _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aRetinoblastoma Protein _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aHe, Hongwei | |
| 700 | 1 | _aFeng, Yun | |
| 700 | 1 | _aZhang, Min | |
| 700 | 1 | _aRen, Kaihuan | |
| 700 | 1 | _aShao, Rongguang | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 17 _gno. 2 _gp. 173-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001813-200602000-00008 _zAvailable from publisher's website |
| 999 |
_c16044438 _d16044438 |
||